An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.
FDA Panel Rejects Use of MDMA for Treatment of PTSD
Written by
in
Drug Abuse and Traffic, Drugs (Pharmaceuticals), Ecstasy (Drug), Food and Drug Administration, Institute for Clinical and Economic Review, Justice Department, Lykos Therapeutics, Medicine and Health, Mental Health and Disorders, Multidisciplinary Assn for Psychedelic Studies, Placebos, Post-Traumatic Stress Disorder, Psychedelic and Hallucinogenic Drugs, Psychiatry and Psychiatrists, Regulation and Deregulation of Industry, Therapy and Rehabilitation, Veterans